Term
|
Definition
0--no pain 2--hurts a little 4--hurts a little more 6--hurts even more 8--hurts whole lot 10--hurts worst Can assess children with smiley faces to indicate or people who cannot speak, etc. |
|
|
Term
|
Definition
Commonly occurs after trauma, surgery, medical procedures resolves in short time frame Examples: the above and muscle strains/sprains
|
|
|
Term
Chronic Non-malignant pain |
|
Definition
Lasting >6 months OR beyond healing period Also non associated with cancer pain Examples: HA, chronic low back, OA & RA, fibromyalgia
|
|
|
Term
|
Definition
pain associate with progressive DZ that is potentially life-limiting (Cancer or its therapy) Can have exacerbations (elements of Acute) Cancer/Chemo, AIDS, end stage organ failure
|
|
|
Term
|
Definition
usually described as a burning, tingling, hypersensitive, electrical shock Due to abnormal sensory input or trauma Not responding well to traditional therapy Examples: Diebetes neuropathy, B-12 neuropathy
|
|
|
Term
|
Definition
Level 1 (pain 1-3)--non-opiod analgesic +/- adjuvant Level 2 (pain 4-7)--weak opiod +/- non-opiod +/- adjuvant Level 3 (pain 8-10)--stong opiod +/- non-opiod +/- adjuvant
|
|
|
Term
|
Definition
After the acute period of treatment or for chronic/rehibilitation Types of heat genreation: dry/moist/convection/microwave Increase blood flow and help remove products of inflammation Do not use immediately or with local anesthetics
|
|
|
Term
|
Definition
creating sensation to hide pain may cause vasodilation or so placebo effect Cooling agents:Camphor and Menthol Rubifacients: Methyl salicylate and Capsaicin
|
|
|
Term
|
Definition
|
|
Term
|
Definition
Antipyretic Anti-inflammatory
--Ceiling effect --DO NOT cause tolerance or dependance |
|
|
Term
|
Definition
Indications: fever (non-inflam component) Advantages: no antiplatlet effect, well tolerated, DOC in kids and renal failure Disadvantages:hepatotoxicity (awareness of other drugs with this in it)
|
|
|
Term
|
Definition
Irrevesibly inhibits platelet action Adverse effects: GI, SE, bleeding Avoid in children <12 yoa Hypersensitivity reaction possible
|
|
|
Term
|
Definition
Acute pain OA RA Gout Bursitis migraines Dysmenorrhea MANY OTHERS
|
|
|
Term
|
Definition
|
|
Term
|
Definition
--NSAID's --non-acetylated salicylates do no interfere wit hplatelet aggregation and rare GI bleeding EX: Salsalate Diflunisal |
|
|
Term
|
Definition
Onset: 1 hr Duration: 12 hrs EX: fenprofen Ibuprofen ketoprofen Naproxen Oxaprozin Flubiprofen (FDA only for OA and RA) |
|
|
Term
|
Definition
Examples: Meloxicam--FDA only for RA and OA Piroxicam--caution in elderly |
|
|
Term
|
Definition
NSAIDS Onset: 1/2 hr Durations: 6-8 hrs
Examples: Diclofenac Etodolac Indomethacin--gout Ketorolac--not exceed 5 days Sulindac Tolmetin |
|
|
Term
|
Definition
Examples: Meclofenamate Mefenamic Acid--not exceed 1 wk |
|
|
Term
|
Definition
NSAIDS Durations 12-24 hrs
Examples: Nabumentone--FDA for RA and OA only (be careful with Heart Failure) |
|
|
Term
|
Definition
Onset: 1hr Duration : 12-24hrs
Celecoxib--only one on market (200mg BID) |
|
|
Term
Adverse Effects of NSAIDS |
|
Definition
GI Renal CNS Dermatology Hematologic Hepatic injury pulmonary pregnancy/lactation
|
|
|
Term
|
Definition
Risks: >60, high dose, past h/o GI toxicity, use with other NSAIDS, anticoags, etc |
|
|
Term
Primary and Secondary prevention/treatment of GI side effects |
|
Definition
1--misoprostol or PPI (lansoprazole, esomeprazole) COX-2 NSAIDs H2 antagonist H. pylori status 2--assess patients needs for NSAIDS Recurrent ulcer--Celecoxib and PPI |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Dermatologic effects of NSAIDS: |
|
Definition
|
|
Term
Other Advers effects of NSAIDS |
|
Definition
|
|
Term
Drug interactions (NSAIDS) |
|
Definition
|
|
Term
Monitoring parameters of NSAIDS |
|
Definition
|
|
Term
Opioids (advantages and disadvantages) |
|
Definition
Ad: --moderate to severe pain --multiple receptor agonist (mu, kappa, delta) --superior benefit to risk --NO ceiling effect DISAD: --addiction/ dependence --respiratory depression --Hypoxia |
|
|
Term
Possible combination therapy for mild to maderate pain (mild opioids) |
|
Definition
Hydrocodone + acetominophen (most common) hydrocodone + ibuprofen Codeine + acetominophen
|
|
|
Term
Principle of chronic opioid therapy |
|
Definition
moderate to severe pain treatment pts. may benefit from using them decrease amount of short acting pain meds insure analgesia throughout night Provide consistant level of pain relief
|
|
|
Term
Strong Full opioid agonists |
|
Definition
•Morphine •Hydromorphone •Oxycodon •Oxymorphone •Methadone •Meperidine •Fentanyl |
|
|
Term
|
Definition
•Codeine •Hydrocodone •Propoxyphene |
|
|
Term
|
Definition
Additonal risk of seizures adjust for renal impairment TENDS not to work as well in people previously on opioid treatment |
|
|
Term
Mixed opioid agonist-antagonists |
|
Definition
--Activate Kappa while inhibiting Mu --Highly addictive Examples: Pentazocine Butorphanol Nalbuphine **no respiratory depression** --should not be used for severe progression of pain --lack euphoric effect --lack of evidence for advantage |
|
|
Term
|
Definition
Long acting opioid GOLD STANDARD Caution with severe renal insufficiency accumulation of metabolites can cause aggitation, confusion and delerium highest insidence of PRURITIS
Examples: MS contin--controlled release tablet (BID) Oramorph SR--sustained release (BID) Kadian--sustained release (BID) Avinza--once a day dosing |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
maintanence therapy in patients with heroin addiction Once a day for addiction dose frequently for pain management 1/2 life not specific (monitor)
|
|
|
Term
Fentanyl (transdermal patches) |
|
Definition
Who should NOT use: --acute, post-op, intermitant and mild pain --those not opioid tolerant |
|
|
Term
|
Definition
put patch o nnon-irritated flat skin surface clip but do not shave hair DO NOT cut patch write date and time of application on patch caution using sauna, hot tubes or heated water beds NO heat on the patch
|
|
|
Term
|
Definition
Morphine oxycodone oxymorphone methadone fentanyl
|
|
|
Term
|
Definition
Morphine sulfate Oxycodone Hydromorphone Fentanyl Oxymorphone
**remember that some are the same as long acting but it is dependent on the trade drug and thus the deliverey system** |
|
|
Term
|
Definition
--pain uccuring on top of the chronic pain --short acting opioid recomended --use same product in short as in long acting --short 10-15% of long acting dose --2-6 hrs prn |
|
|
Term
|
Definition
routes: IM, IV, SQ, tablet, supository, liquid Onset: 15-30 minutes Peak: 1/2-1hr
|
|
|
Term
Actiq ora transmucousal Fentanyl |
|
Definition
--sweetened lozenge on a stick --only a portion of the drug is absorbed --15 minute consumption --peak:5-10min. --start the lowest dose --CAN repeat in 15 min. after 1st dose |
|
|
Term
Fentora (effervescent bucal tablet) |
|
Definition
Lozenge always has higher dose than buccal |
|
|
Term
|
Definition
short deration of action Toxic metabolite which can induce tremor, twitching, agitation and covulsions Should NOT be given more than 48 hrs for acute pain NEVER use with chronic pain
|
|
|
Term
|
Definition
•Constipation •Nausea and vomiting--usualy at start of treatment •Drowsiness and sedation--usually resolve in few days •Respiratory depression •Itching and pruritus--dyphenhydramine •Pseudoallergy vs true allergy |
|
|
Term
|
Definition
MOST common opioid side effect delay gastic emptying, decrease parastalsis, slow down bowel movement Treat with stimulant laxative +/- stool softener CAUTION use of bulk forming laxatives
|
|
|
Term
|
Definition
|
|
Term
Initiating Opioid Therapy In An Opioid Naïve Patient |
|
Definition
Long acting not recomended immediate release prefered once stable can switch to long acting lowest effective dose
|
|
|
Term
|
Definition
When patient is nto getting sufficient pain relief compaining of adverse reactions need for change of method of deleivery
|
|
|
Term
IV = PO dosing for Morphine hydrocodone oxycodone |
|
Definition
M 10 = 30 mg H 1.5 = 7.5mg O only PO |
|
|
Term
INCOMPLETE CROSS TOLERANCE AND OPIOID CONVERSIONS |
|
Definition
|
|
Term
Opioids use for PCA (patient controlled analgesia) |
|
Definition
Morphine fentanyl hadromorphone
--patient self administering narcotic --preprogrammed with a lockout period --most post-op patients after the continuous basal infusion is being tappered (3-5 days post-op) |
|
|
Term
|
Definition
--Add to any regimen --Many agents used for neuropathic pain EX. Antidepressants Anticonvulsants Steroids |
|
|
Term
|
Definition
|
|
Term
|
Definition
Examples= pregabalin and gabapentin --increasingly used for cancer pain sedation or neurotransmitter inpuls block |
|
|
Term
|
Definition
GABA agonist Carbamate Depressant Antihistamine analog tricyclic agent Direct skeletal relaxer
|
|
|
Term
|
Definition
|
|
Term
GABA agonist (precautions) |
|
Definition
Do not stop abruptly (2 wk tapper) Renal dosing needed ELDERLY Psychiatric disorders admin...oral or intratracheal CNS depression at large dose
|
|
|
Term
|
Definition
enhances GABE inhibitory neurotransmitter system, specifically GABA-A and DNZ receptor Indications: spasmodic torticollis adjunct or joint dislocation neurodegenerative disorders MAX 40 mg/day oral
|
|
|
Term
|
Definition
|
|
Term
|
Definition
Carbamate Depressant centrally acting sedative use: muscle spasms 350mg po 3-4 times/day Dependency possible additive properties with alcohol Can combine with ASA or codein
adverse reactions: drowsiness, sedation, vertigo |
|
|
Term
|
Definition
renal and hepatic impairment LOWER seizure threshhold NOT <16yoa |
|
|
Term
|
Definition
|
|
Term
|
Definition
Central Depressant and Sedative use: Skeletal Muscle spasms NOT < 12 yoa or in the elderly (renal or hepatic impairment) CONTRAINDICATIONS: hemolytic anemia
|
|
|
Term
|
Definition
Antihystamine analog anticholenergic, stimulant, local analgesic (not for degenerative disorder) Indications: nocturnal leg cramp, muscle spasms, parkinson SE: anticholenergic (dry mouth, blurred vision, etc.)
|
|
|
Term
|
Definition
Side Effects: --anticholinergic --not excede 2-3 wks --LOWER seizure threshold --accumulation --not effective for depression |
|
|
Term
|
Definition
|
|
Term
|
Definition
--pregnancy (C) --Drowsiness --driving while on meds Withdraw: baclofen, carisoprodol, diazepam |
|
|
Term
Combinations with muscle relaxers |
|
Definition
Aspirin NSAIDS and COX-2 Caffeine Codeine
|
|
|